Antipsychotic Monotherapy vs Polytherapy for Pneumonia Risk-Reply

Jurjen J. Luykx; Jari Tiihonen; Heidi Taipale

doi:10.1001/jamapsychiatry.2024.3327

Antipsychotic Monotherapy vs Polytherapy for Pneumonia Risk-Reply

Jurjen J. Luykx
, Jari Tiihonen
, Heidi Taipale

Karolinska Institutet
University of Eastern Finland
Stockholm City Council

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1278-1279
Number of pages	2
Journal	JAMA psychiatry
Volume	81
Issue number	12
DOIs	https://doi.org/10.1001/jamapsychiatry.2024.3327
Publication status	Published - 1 Dec 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1001/jamapsychiatry.2024.3327

Cite this

@article{ec21a0b8689b443699e6d6510fdf9a92,

title = "Antipsychotic Monotherapy vs Polytherapy for Pneumonia Risk-Reply",

author = "Luykx, \{Jurjen J.\} and Jari Tiihonen and Heidi Taipale",

year = "2024",

month = dec,

day = "1",

doi = "10.1001/jamapsychiatry.2024.3327",

language = "English",

volume = "81",

pages = "1278--1279",

journal = "JAMA psychiatry",

issn = "2168-622X",

publisher = "American Medical Association",

number = "12",

}

TY - JOUR

T1 - Antipsychotic Monotherapy vs Polytherapy for Pneumonia Risk-Reply

AU - Luykx, Jurjen J.

AU - Tiihonen, Jari

AU - Taipale, Heidi

PY - 2024/12/1

Y1 - 2024/12/1

UR - https://www.scopus.com/pages/publications/85211679775

U2 - 10.1001/jamapsychiatry.2024.3327

DO - 10.1001/jamapsychiatry.2024.3327

M3 - Article

C2 - 39441573

AN - SCOPUS:85211679775

SN - 2168-622X

VL - 81

SP - 1278

EP - 1279

JO - JAMA psychiatry

JF - JAMA psychiatry

IS - 12

ER -

Antipsychotic Monotherapy vs Polytherapy for Pneumonia Risk-Reply

UN SDGs

Access to Document

Other files and links

Cite this